Death Due to COVID-19 in an Infant with Combined Immunodeficiencies

Author(s): Hamid Ahanchian, Nasrin Moazzen*, Amin Saeidinia, Seyed H. Joghatayi, Maryam Khoshkhui, Mohammad H. Aelami, Nasrin S. M. Haghi, Nima Rezaei*

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 21 , Issue 9 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Severe Acute Respiratory Syndrome Coronavirus 2 has affected millions of people, and especially in adult patients with underlying diseases lead to death. Meanwhile pediatric patients with inherited defects of T cell should be prone to viral diseases.

Case Presentation: Herein, we report an infant with severe combined immunodeficiencies, who were affected and died because of COVID-19.

Conclusion: Considering the importance of finding how immune system can affect the viral infection, presentation of COVID-19 in immune deficient patients can be valuable.

Keywords: Combined immunodeficiency, COVID-19, cardiac injury, infant, death, bone marroow.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 9
Year: 2021
Published on: 21 October, 2020
Page: [1649 - 1652]
Pages: 4
DOI: 10.2174/1871530320666201021142313
Price: $65

Article Metrics

PDF: 309